|
Fe3O4@TiO2
|
0 nM
|
100 nM
|
250 nM
|
|
SK-N-AS
|
0 Gy
|
100 ± 2.22
|
100 ± 2.00
|
100 ± 1.42
|
|
2 Gy
|
88.15 ± 2.85
|
88.10 ± 3.60
|
82.22 ± 2.50**
|
|
5 Gy
|
60.00 ± 1.63
|
59.61 ± 1.73
|
50.30 ± 4.49**
|
|
10 Gy
|
38.90 ± 3.16
|
38.40 ± 4.53
|
32.35 ± 2.49**
|
|
SK-N-DZ
|
0 Gy
|
100 ± 7.42
|
100 ± 9.29
|
100 ± 1.86
|
|
2 Gy
|
78.68 ± 2.70
|
77.00 ± 3.18
|
74.55 ± 3.18
|
|
5 Gy
|
52.13 ± 2.46
|
51.35 ± 2.47
|
46.89 ± 1.64**
|
|
10 Gy
|
31.14 ± 2.78
|
29.01 ± 3.53
|
25.03 ± 2.05**
|
- Table of cell viabilities (expressed as % of non-irradiated treatment control for a given concentration of nanoconjugates, after adjustment for baseline cytotoxicity) for SK-N-AS and SK-N-DZ cells treated with varying concentrations of bare nanocomposites and different doses of ionizing radiation (Fig. 5). Entries contain mean ± SD. **: < 0.01 significance level, *** < 0.001 significance level.
